Literature DB >> 16786116

Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.

Nozomi Amaoka1, Masanao Saio, Kenichi Nonaka, Hisashi Imai, Hiroyuki Tomita, Fumio Sakashita, Takao Takahashi, Yasuyuki Sugiyama, Tsuyoshi Takami, Yosuke Adachi.   

Abstract

Angiogenesis is important for tumor growth, and is regulated by angiogenetic factors such as vascular endothelial growth factor (VEGF). In the present study, we investigated whether or not expression of VEGF receptors (VEGFRs) is related to the proliferation of tumor cells in hepatocellular carcinoma (HCC). We simultaneously stained proliferation marker Ki-67 antigen and either VEGFR1 (Flt-1) or VEGFR2 (Flk-1) on paraffin-embedded tissue sections from 50 cases of surgically resected human HCC. Based on the staining pattern of VEGFRs, we classified the cases into 4 categories; receptor double-negative, Flt-1 single-positive, Flk-1 single-positive, receptor double-positive. Interestingly, the Ki-67 index was significantly lower in receptor double-negative cases in comparison to that in either Flt-1 single-positive or Flk-1 single-positive cases (P = 0.0491, P = 0.0196, respectively). Moreover, the index was also significantly lower in receptor double-positive cases in comparison to either Flt-1 single-positive or Flk-1 single-positive cases (P = 0.0026, P < 0.0001, respectively). We further investigated 35 cases showing a Ki67 index > 10% to determine the expression of VEGFRs on Ki-67 antigen-positive proliferating cells. Surprisingly, the histological grade of HCC and the expression pattern of VEGFRs showed a characteristic relation; the well-differentiated HCC cases were all distributed in the Flk-1-positive group (7/7), moderately differentiated HCC cases were distributed in either the Flt-1 or Flk-1 single-positive group (20/21), and poorly differentiated HCC cases were predominantly distributed in either the receptor double-negative or double-positive group (6/7). These findings suggest that the expression pattern of VEGFRs influences the histological differentiation of HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786116

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Lihui Han; Wanhua Ren; Hui Liu; Chengyong Qin
Journal:  Future Oncol       Date:  2015-11-09       Impact factor: 3.404

2.  High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Wanhua Ren; Shifeng Xu; Zhen Yang; Aiju Fang; Chengyong Qin
Journal:  Med Oncol       Date:  2012-01-15       Impact factor: 3.064

3.  The patterns and expression of KDR in normal tissues of human internal organs.

Authors:  Jianfei Huang; Huijun Zhu; Xudong Wang; Qi Tang; Hua Huang; Kerong Wu; Jin Zhu; Zhenqing Feng; Gongshen Shi
Journal:  J Mol Histol       Date:  2011-09-10       Impact factor: 2.611

4.  VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.

Authors:  Alexander Schultze; Isabel Ben Batalla; Sabine Riethdorf; Michael Bubenheim; Emre Yekebas; Andreas Erbersdobler; Uta Reichelt; Katharina E Effenberger; Thomas Schmidt; Jakob R Izbicki; Carsten Bokemeyer; Klaus Pantel; Walter Fiedler; Sonja Loges
Journal:  Clin Exp Metastasis       Date:  2012-04-08       Impact factor: 5.150

5.  Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma.

Authors:  Gassimou Bangoura; Zhi-Su Liu; Qun Qian; Cong-Qing Jiang; Gui-Fan Yang; Sun Jing
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

6.  Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.

Authors:  Justin Monnier; Claire Piquet-Pellorce; Jean-Jacques Feige; Orlando Musso; Bruno Clement; Bruno Turlin; Nathalie Theret; Michel Samson
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

7.  Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.

Authors:  Charles S Harmon; Samuel E DePrimo; Eric Raymond; Ann-Lii Cheng; Eveline Boucher; Jean-Yves Douillard; Ho Y Lim; Jun S Kim; Maria José Lechuga; Silvana Lanzalone; Xun Lin; Sandrine Faivre
Journal:  J Transl Med       Date:  2011-07-25       Impact factor: 5.531

8.  The evaluation of anti-angiogenic effects of Endostar on rabbit VX2 portal vein tumor thrombus using perfusion MSCT.

Authors:  Guoquan Feng; Zhen Lei; Dongqing Wang; Na Xu; Qiang Wei; Dinuo Li; Jingyi Liu
Journal:  Cancer Imaging       Date:  2014-04-28       Impact factor: 3.909

9.  Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.

Authors:  Peng-Yuan Zhuang; Jun Shen; Xiao-Dong Zhu; Lu Lu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.